Abstract
Thirteen elderly depressed patients (age 60–82 years) were treated for 5 weeks with a fixed dose of amitriptyline 100 mg (sustained release preparation). In all patients the sum of concentrations of amitriptyline and nortriptyline exceeded 130 μg/l, which is the recommended plasma level. Cardiovascular side effects were recorded by monitoring heart rate, blood pressure, standard ECG and systolic time intervals. During treatment, a transient increase in the supine heart rate was observed without significant changes in the supine blood pressure. The orthostatic drop in blood pressure was markedly increased during treatment without a compensatory increase in heart rate, and these changes remained significant during the whole investigational period. PQ and QRS were significantly increased during treatment, and significant changes in the systolic time intervals were found indicating impairment of myocardial conduction and contractility. In three patients medication was discontinued due to cardiovascular side effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Åsberg M, Cronholm B, Sjöqvist F, Tuck D (1970) Correlation of subjective side effects with plasma concentrations of nortriptyline. Br Med J 4:18–21
Bertram U, Kragh-Sørensen P, Rafaelsen OJ, Larsen N-E (1979) Saliva secretion following long-term antidepressant treatment with nortriptyline controlled by plasma levels. Scand J Dent Res 87:58–64
Burckhardt D, Raeder E, Müller V, Imhof P, Neubauer H (1978) Cardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA 239:213–216
Burgess CD, Montgomery S, Wadsworth J, Turner P (1979) Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients. Postgrad Med J 55:704–708
Fleisch JH (1981) Age-related decrease in beta-adrenoceptor activity of the cardiovascular system. TIPS 2:337–339
Glassman AH, Bigger JT (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatr 38:815–820
Gram LF, Søndergård I, Christiansen J, Petersen GO, Bech P, Reisby N, Ibsen I, Ortmann J, Nagy A, Dencker SJ, Jacobsen O, Krautwald O (1977) Steady-state kinetics of imipramine in patients. Psychopharmacology 54:255–261
Gram LF (1983) Antidepressants: Receptors, pharmacokinetics and clinical effects. In: Burrows GD, Norman TR, Davis B (eds). Drugs in psychiatry, volume I, Antidepressants. Elsevier/North-Holland Biomedial Press BV, Amsterdam 1983, pp 81–96
Gurney C, Roth M, Garside RF, Kerr TA, Schapira K (1972) Studies in the classification of affective disorders. The relationship between anxiety states and depressive illnesses. J Psychiatr 121:162–166
Hamilton M (1967) Development of a rating scale for primary depressive illness. J Soc Clin Psychol 6:278–296
Kragh-Sørensen P, Larsen N-E (1980) Factors influencing nortriptyline steady-state kinetics: plasma and saliva levels. Clin Pharmacol Ther 28:796–803
Kristiansen ES (1961) Cardiac complications during treatment with imipramine (tofranil). Acta Psychiat Scand 36:427–442
Kristjansen P, Poulsen H (1963) Grenblok som bivirkning ved amitriptylin-behandling. Ugeskr Læg 125:394–395
Lakatta EG (1980) Age-related alterations in the cardiovascular response to adrenergic mediated stress. Fed Proc 39:3173–3177
Møller M, Thayssen P, Kragh-Sørensen P, Pedersen OL, Kristensen CB, Bjerre M, Benjaminsen S, Gram LF (1983) Mianserin: Cardiovascular effects in elderly patients. Psychopharmacology 80:174–177
Nagy A, Treiber L (1973) Quantitative determination of imipramine and desimipramine in human blood plasma by direct densiometry of thin-layer chromatograms. J Pharm Pharmacol 25:599–603
Nielsen JR, Johansen T, Arentoft A, Gram LF (1983) Effects of imipramine on the orthostatic changes in blood pressure, heart rate and catecholamines. Clin Exp Pharmacol Physiol 10:497–504
Nies A, Robinson DS, Friedman MJ, Green R, Cooper TB, Ravaris CL, Ives JO (1977) Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 134:790–793
Peet M, Tienari P, Jaskari MO (1977) A comparison of the cardiac effects of mianserin and amitriptyline in man. Pharmacopsychiat Neuropsychopharmacol 10:309–312
Raeder E, Burckhardt D, Neubauer H, Walter R, Gastpar M (1978) Long-term tri- and tetra-cyclic antidepressants, myocardial contractility and cardiac rhythm. Br Med J 2:666–667
Rowe JW, Troen BR (1980) Sympathetic nervous system and aging in man. Endocr Rev 1:167–179
Smith RB, Rusbatch BJ (1967) Amitriptyline and heart block. Br Med J 3:311
Taylor JE, Braithwaite RA (1978) Cardiac effects of tricyclic antidepressant medication. Br Heart J 40:1005–1009
Thayssen P, Bjerre M, Kragh-Sørensen P, Møller M, Pedersen OL, Kristensen CB, Gram LF (1981) Cardiovascular effects of imipramine and nortriptyline in elderly patients. Psychopharmacology 74:360–364
Videbæk J (1979) Isometric pressure indices. Thesis, Copenhagen
Weissler AM, Harris WS, Schoenfeld CD (1968) Systolic time intervals in heart failure in man. Circulation 37:149–159
Weissler AM, Harris WS, Schoenfeld CD (1969) Bedside technics for the evaluation of ventricular function in man. Am J Cardiol 23:577–583
Ziegler VE, Co BT, Biggs JT (1977) Electrocardiographic findings in patients undergoing amitriptyline treatment. Dis Nerv Syst 38:697–699
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Christensen, P., Thomsen, H.Y., Pedersen, O.L. et al. Cardiovascular effects of amitriptyline in the treatment of elderly depressed patients. Psychopharmacology 87, 212–215 (1985). https://doi.org/10.1007/BF00431810
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431810